糖尿病
医学
2型糖尿病
内科学
血压
胰岛素抵抗
队列研究
风险因素
队列
前瞻性队列研究
内分泌学
作者
Zhou‐Zheng Tu,Yuan Yu,Peng‐Fei Xia,Qi Lu,Shuohua Chen,Guodong Wang,Mengyi Zheng,Yanbo Zhang,Jun‐Xiang Chen,Yanfeng Zhou,Gang Liu,Shouling Wu,An Pan
标识
DOI:10.1016/j.diabet.2022.101348
摘要
China has the largest number of adults with diabetes. Although multiple metabolic risk factors (MRFs) are implicated in the development of diabetes, it remains unclear how they progress during the development of diabetes among Chinese. We examined trajectories of multiple MRFs among Chinese and identified the critical period when drastic changes occurred during the development of diabetes.This prospective cohort study included participants since 2006-2007 in the Kailuan study. People attended biennial examinations until 2017 with additions of new participants at each examination cycle. The time when a participant first completed the examination was served as the baseline. A total of 122,659 participants without prevalent diabetes at baseline and with complete follow-up data were included. MRFs were collected via biennial physical examinations and laboratory measures. Incident diabetes cases were identified via biennial fasting glucose tests and self-reported physician-diagnosis.During up to 12 years of follow-up, 14,922 incident diabetes cases were identified. Compared with participants who did not develop diabetes, those who developed diabetes had more adverse levels of most MRFs at baseline and during follow-up. Abrupt increases in multiple MRFs (including fasting glucose, surrogate insulin resistance indicators, lipids, systolic blood pressure, pulse pressure, heart rate, alanine aminotransferase, and C-reactive protein) were observed 3 years before the diagnosis of diabetes.We identified 3 years before diabetes diagnosis as a critical period when multiple MRFs experienced drastic changes. This would have implications for early monitoring and timely prevention for individuals who experience sudden adverse progression of multiple MRFs.
科研通智能强力驱动
Strongly Powered by AbleSci AI